These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9247769)

  • 1. Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension.
    Burrell LM; Risvanis J; Phillips PA; Naitoh M; Johnston CI
    Clin Exp Hypertens; 1997; 19(5-6):981-91. PubMed ID: 9247769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salusin-β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats.
    Chen WW; Sun HJ; Zhang F; Zhou YB; Xiong XQ; Wang JJ; Zhu GQ
    Cardiovasc Res; 2013 Jun; 98(3):344-51. PubMed ID: 23400761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat.
    Fraser TB; Turner SW; Wen C; Li M; Burrell LM; Whitworth JA
    Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):866-70. PubMed ID: 11071300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.
    Yamamura Y; Ogawa H; Chihara T; Kondo K; Onogawa T; Nakamura S; Mori T; Tominaga M; Yabuuchi Y
    Science; 1991 Apr; 252(5005):572-4. PubMed ID: 1850553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
    Alánová P; Husková Z; Kopkan L; Sporková A; Jíchová Š; Neckář J; Imig JD; Klevstig M; Kolář F; Rami Reddy N; Falck JR; Sadowski J; Nishiyama A; Kramer HJ; Melenovský V; Červenková L; Kujal P; Vernerová Z; Červenka L
    Vascul Pharmacol; 2015 Oct; 73():45-56. PubMed ID: 26304700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.
    Li P; Huang PP; Yang Y; Liu C; Lu Y; Wang F; Sun W; Kong XQ
    J Appl Physiol (1985); 2017 Jan; 122(1):121-129. PubMed ID: 27742806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats.
    Hashimoto J; Imai Y; Minami N; Munakata M; Abe K
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):548-54. PubMed ID: 8569214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key amino acids of vasopressin V1a receptor responsible for the species difference in the affinity of OPC-21268.
    Shinoura H; Take H; Itoh S; Hirasawa A; Inoue K; Ohno Y; Hashimoto K; Tsujimoto G
    FEBS Lett; 2000 Jan; 466(2-3):255-8. PubMed ID: 10682838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPC-21268, a vasopressin V1 antagonist, produces hypotension in spontaneously hypertensive rats.
    Yamada Y; Yamamura Y; Chihara T; Onogawa T; Nakamura S; Yamashita T; Mori T; Tominaga M; Yabuuchi Y
    Hypertension; 1994 Feb; 23(2):200-4. PubMed ID: 8307629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys.
    Soltani Hekmat A; Najafipour H; Nekooian AA; Esmaeli-Mahani S; Javanmardi K
    Regul Pept; 2011 Dec; 172(1-3):62-8. PubMed ID: 21911011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.
    Serradeil-Le Gal C; Wagnon J; Valette G; Garcia G; Pascal M; Maffrand JP; Le Fur G
    Prog Brain Res; 2002; 139():197-210. PubMed ID: 12436936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat).
    Theilig F; Debiec H; Nafz B; Ronco P; Nüsing R; Seyberth HW; Pavenstädt H; Bouby N; Bachmann S
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F987-94. PubMed ID: 16788145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an orally active vasopressin V1 receptor antagonist.
    Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide anions involved in sympathoexcitation and pressor effects of salusin-β in paraventricular nucleus in hypertensive rats.
    Sun HJ; Zhang LL; Fan ZD; Chen D; Zhang L; Gao XY; Kang YM; Zhu GQ
    Acta Physiol (Oxf); 2014 Mar; 210(3):534-45. PubMed ID: 24304512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vasopressin on cardiovascular changes during hemorrhage in conscious rats.
    Fujisawa Y; Miyatake A; Hayashida Y; Aki Y; Kimura S; Tamaki T; Abe Y
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1713-8. PubMed ID: 7977803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin receptor expression in ischemic and non- ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats.
    Najafipour H; Soltani Hekmat A; Nekooian AA; Esmaeili-Mahani S
    Regul Pept; 2012 Oct; 178(1-3):43-50. PubMed ID: 22796316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
    Burrell LM; Phillips PA; Risvanis J; Aldred KL; Hutchins AM; Johnston CI
    Hypertension; 1995 Nov; 26(5):828-34. PubMed ID: 7591025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat.
    Tachikawa K; Yokoi H; Nagasaki H; Arima H; Murase T; Sugimura Y; Miura Y; Hirabayashi M; Oiso Y
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1161-6. PubMed ID: 12915399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260).
    Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Johnston CI
    Blood Press; 1994 Mar; 3(1-2):137-41. PubMed ID: 8199714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.